Abstract
Intestinal bacteria play an important role for the metabolism of soy isoflavonoids. When soy foods are consumed, the soy isoflavone glucosides are metabolized into their aglycones and the related isoflavonoids by intestinal bacteria. We designed an in vitro microbial metabolic system using 29 commercially available human intestinal bacterial strains and elucidated the metabolism of soy isoflavone glucosides. The strains were classified into three categories, which were 14 facultative anaerobes, 13 obligate anaerobes, and 2 aerobes. Almost all facultative anaerobe strains metabolized soy isoflavone glucosides to their aglycones. The ratio of metabolism from glucoside to aglycone was different in each strain. Contrary to the facultative anaerobes, some of the obligate anaerobes did not metabolize soy isoflavone glucosides at all. Both the aerobic bacteria hardly metabolized soy isoflavone glucosides. The bacterial growth speed might show good correlation to the metabolizing speed of both glucosides. Therefore, the speed of metabolism would be different in each bacterial strain, too.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Some epidemiological studies have demonstrated that the intake of soy foods containing isoflavonoid phytoestrogens may reduce the risk of some hormone-dependent diseases, such as not only postmenopausal symptoms, but also certain cancers (breast, prostate, and colon) and cardiovascular diseases [1–4]. With the publicity given to the benefit of soy isoflavonoids for human health, the consumption of dietary supplements derived from soybeans has increased significantly.
When soy foods are consumed, the soy isoflavonoids (isoflavone glucosides) are metabolized into their aglycones by intestinal bacteria at first (Fig. 1). Then the metabolites are absorbed through the gastrointestinal membrane and are brought to the liver. Finally, they are further metabolized in the liver to yield various conjugated forms [5–7]. We have already reported about the structures of soy isoflavonoid metabolites excreted in human urine together with their estrogenic activities [8, 9]. In the first step, intestinal bacteria play an important role for the metabolism of soy isoflavone glucosides. They are greatly responsible for catabolism and scission of the isoflavonoids [10]. The reductive products of soy isoflavonoids, for example, equol and O-desmethylangolensin (DMA), showed stronger estrogenic activity than soy isoflavone aglycone (daidzein) itself [9, 11]. Therefore, it seems to be very important for elucidation of the soy isoflavonoid metabolism by intestinal bacteria.
Herein, we report the microbial transformation of soy isoflavone glucosides using 29 bacterial strains (14 strains of facultative anaerobe, 13 strains of obligate anaerobe, and 2 strains of aerobe) isolated from the human gastrointestinal tract.
Materials and methods
Bacterial strains
Bifidobacterium adolescentis JCM1275, Bifidobacterium bifidum JCM1254, Bifidobacterium longum JCM1217, Bifidobacterium breve JCM7016, Bifidobacterium pseudocatenulatum JCM1200, Bifidobacterium pseudolongum subsp. pseudolongum JCM1205, Lactobacillus acidophilus JCM1132, Lactobacillus gasseri JCM1131, Lactobacillus reuteri JCM1112, Lactobacillus brevis JCM1059, Lactobacillus paracasei subsp. Paracasei JCM1109, Lactobacillus ermentum JCM1560, Streptococcus bovis JCM7891, Enterococcus faecalis JCM5803, Bacteroides vulgatus JCM5826, Bacteroides distasonis JCM5825, Bacteroides thetaiotaomicron JCM5827, Bacteroides ovatus JCM5824, Bacteroides fragilis JCM11019, Mitsuokella multacida JCM2054, Clostridium celatum JCM1394, Clostridium ramosum JCM1298, Clostridium spiroforme JCM1432, Peptostreptococcus productus JCM1471, Peptostreptococcus hydrogenalis JCM7635, Fusobacterium nucleatum JCM6328, Prevotella veroralis JCM6290, Klebsiella pneumoniae JCM1662, and Escherichia coli JCM5491 were purchased from the Japan Collection of Microorganisms (RIKEN BioResource Center, Ibaraki, Japan).
Culture conditions
Each bacterial strain was maintained in general anaerobic medium (GAM) semisolid. It was inoculated into GAM broth (Nissui Co., Tokyo, Japan), then was continuously cultured at 37°C in the anaerobic chamber. The air was replaced by mixed gas (N2 80%, CO2 10%, H2 10%) together with AnaeroPack Kenki (Mitsubishi Gas Chemical Co. Inc., Tokyo, Japan) for anaerobic conditions. Each bacterial strain (1 ml) precultured for 24 h in GAM broth was inoculated into 10 ml of GAM broth containing 2 mg soy isoflavones (genistin and daidzin). The culture medium was incubated at 37°C for 24 h. The cultured medium was extracted three times with ethyl acetate, then was evaporated to dryness under reduced pressure. The residue was analyzed by HPLC.
HPLC analysis of metabolism
The HPLC system consisted of CCPM-II pump, UV-8020 UV detector (Tosoh, Tokyo, Japan). HPLC conditions were as follows: column: C18 reversed-phase column (Cadenza CD-C18 3 μm, 150 mm × 4.6 mm i.d., Imtakt Co. Inc., Kyoto, Japan), solvent A: H2O with 0.05% trifluoroacetic acid (TFA), solvent B: H2O:CH3CN (4:6) with 0.05% TFA, column temperature: 40°C, flow rate: 1 ml/min. Elution was done by the following process: solvent A: solvent B (7:3, 0 min) → solvent A: solvent B (35:65, 20 min). All of the samples were detected at 254 nm.
Time course experiments of metabolism
Some bacterial strains (0.1 ml) precultured for 24 h in GAM broth were inoculated into 1.1 ml of GAM broth containing 0.1 mg soy isoflavonoid (daidzin, genistin). The culture medium was incubated under anaerobic conditions in a similar manner as above for designated times (0, 3, 6, 12, and 24 h). The growth of bacteria was evaluated by turbidity (absorbance at 595 nm). Each cultured medium was purified over Oasis HLB cartridges (Waters, Milford, MA); the H2O–MeOH (19:1) washing step was followed by 100% MeOH. The MeOH fr. was evaporated (under N2 stream at 40°C), and the residue was taken up by 500 μl of H2O–MeOH (1:9). The sample solution was analyzed by HPLC. HPLC conditions were as follows: column: C18 reversed-phase column (Cadenza CD-C18 3 μm, 150 mm × 3.0 mm i.d., Imtakt), flow rate: 0.75 ml/min. The elution processes for daidzin was [solvent A: solvent B (75:25, 0 min) → solvent A: solvent B (7:93, 10 min)], for genistin was [solvent A: solvent B (70:30, 0 min) → solvent A: solvent B (0:100, 10 min) → solvent A: solvent B (0:100, 11 min)]. All other HPLC conditions were the same as above.
Results
Six strains of Bifidobacterium genus and Lactobacillus genus along with Enterococcus faecalis and Streptococcus bovis were used as a typical facultative anaerobe, which was called lactic acid bacteria (Table 1). Almost all strains metabolized soy isoflavone glucosides to their aglycones, i.e., from genistin and daidzin to genistein and daidzein, respectively. However, one Bifidobacterium (B. bifidum) and three Lactobacillus (L. brevis, L. ermentum and L. reuteri) strains could not appreciably convert isoflavone glucosides to their aglycones. The ratio of metabolism from glucoside to aglycone was different in each strain of facultative anaerobe. Especially Lactobacillus gasseri showed 100% productive rate from genistin to genistein, although that from daidzin to daidzein was 60%. This strain seems to recognize the structural difference between genistin and daidzin.
Five strains of Bacteroides genus, three strains of Clostridium genus, and two strains of Peptostreptococcus genus along with Fusobacterium nucleatum, Mitsuokella multacida and Prevotella veroralis were used as a typical obligate anaerobes (Table 1). Contrary to the facultative anaerobe, some of obligate anaerobes (B. vulgatus, C. spiroforme, F. nucleatum, and Peptostreptococcus hydrogenalis) did not metabolize soy isoflavone glucosides at all. In addition, M. multacida and Prevotella veroralis could not appreciably convert into aglycones. Contrary to Lactbacillus gasseri of the facultative anaerobes, Bacteroides thetaiotaomicron showed a higher productive rate to daidzein than to genistein. Although the total yield of aglycones was not good, Clostridium celatum produced more daidzein than genistein.
Klebsiella pneumoniae and Escherichia coli were used as typical aerobes. Both the aerobic bacteria hardly metabolized soy isoflavone glucosides.
Bifidobacterium adolescentis, Lactobacillus acidophilus, Bacteroides distasonis, Clostridium ramosum, and Peptostreptococcus productus were used for the time course experiments (Fig. 2) of soy isoflavone metabolism since these strains converted to aglycones in good yield. The order of growth speed was Bifidobacterium adolescentis > Clostridium ramosum >> Peptostreptococcus productus >> Bacteroides distasonis > Lactobacillus acidophilus (Fig. 2c), although the saturated time for growth of each bacterial strain was different. In the hydrolysis, Bifidobacterium adolescentis and Clostridium ramosum metabolized both glucosides within 6 h (Figs. 2a, b ). On the other hand, Lactobacillus acidophilus and Bacteroides distasonis metabolized very slowly (within 24 h). Peptostreptococcus productus showed moderate activity. Therefore, it seemed that the bacterial growth speed showed good correlation to the metabolizing speed of both glucosides.
Discussion
These results indicated that the metabolism from soy isoflavone glucosides to their aglycones was performed by various bacterial strains except for aerobes (Table 1). However, Hur et al. [12] reported that Escherichia coli of aerobes metabolized daidzin and genistin into their aglycones. It might be caused by the difference between strain levels, even if the bacteria had the same scientific name. The difference between facultative anaerobes and obligate anaerobes was not largely observed. Many microbial enzymes were found to possess broad substrate specificity, yet they catalyze reactions with a high degree of regio- and stereospecificity [13]. Some of the bacterial strains (Lactbacillus gasseri, Bacteroides thetaiotaomicron, and Clostridium celatum) showed specific hydrolysis for the glucosidic unit of daidzin rather than that of genistin (Table 1). However, no other reaction, such as reduction or scission, was observed in this experiment. Namely, dihydrodaidzein, equol, O-DMA, dihydrogenistein, 5-hydroxyequol, and 6-hydroxy-O-DMA were not detected in the metabolic studies. Therefore, the metabolic enzyme in these bacterial strains might have the nature of glucosidase only. In the time course experiments of soy isoflavone metabolism (Fig. 2), Bifidobacterium adolescentis of facultative anaerobes and Clostridium ramosum of obligate anaerobes metabolized more rapidly than the other strains, whereas the metabolizing speed of Lactobacillus acidophilus of facultative anaerobes and Bacteroides distasonis of obligate anaerobes was very slow. The order of metabolizing speed would be parallel to that of the growth speed of each bacterial strain(Fig. 2c).
It was known that the Bifidobacterium, Lactobacillus, and Streptococcus genus colonized in the upper gastrointestinal tract, for example, the oral cavity, stomach, and duodenum. Therefore, soy isoflavone glucosides would be metabolized in the early stage after administration. The greater part of soy isoflavone aglycones could be absorbed before further reductive reaction, since the reductive product appeared later than isoflavone aglycone in plasma [14, 15]. Consequently, long-term incubation in consideration of enterohepatic circulation may be needed to obtain the reductive products of soy isoflavone aglycones [16, 17]. Moreover, since the flora constitution of intestinal bacteria was different in each individual [18, 19], combination culture using some bacterial strains [20] might be usuful to obtain the reductive products.
References
Rose DP, Boyar AP, Wynder EL (1986) International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 58:2363–2371
Adlercreutz H (1998) Epidemiology of phytoestrogens. Baillier’s Clinic Endocrinol Metabol 12:605–623
Barnes S (1998) Evolution of the health benefits of soy isoflavones. Proc Soc Exp Biol Med 217:386–392
Clarkson TB, Anthony MS (1998) Phytoestrogens and coronary heart disease. Baillier’s Clinic Endocrinol Metabol 12:589–604
Yasuda T, Kano Y, Saito K, Ohsawa K (1994) Urinary and biliary metabolites of daidzin and daidzein in rats. Biol Pharm Bull 17:1369–1374
Yasuda T, Mizunuma S, Kano Y, Saito K, Ohsawa K (1996) Urinary and biliary metabolites of genistein in rats. Biol Pharm Bull 19:413–417
Yasuda T, Ueda J, Ohsawa K (2001) Urinary metabolites of genistein administered orally to rats. Chem Pharm Bull 49:1495–1497
Tsuchihashi R, Okawa M, Nohara T, Okabe H, Kinjo J (2004) Soy isoflavone metabolites isolated from human urine. Nat Med 58:71–75
Kinjo J, Tsuchihashi R, Morito K, Hirose T, Aomori T, Nagao T, Okabe H, Nohara T, Masamune Y (2004) Interactions of phytoestrogens with estrogen receptors α and β (III). Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine. Biol Pharm Bull 27:185–188
Herath W, Mikell JR, Hale AL, Ferreira D, Khan IA (2006) Microbial metabolism. Part 6. Metabolites of 3- and 7-hydroxyflavones. Chem Pharm Bull 54:320–324
Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, Masamune Y (2001) Interaction of phytoestrogens with estrogen receptors α and β. Biol Pharm Bull 24:351–356
Hur HG, Lay JO Jr, Beger RD, Freeman JP, Rafii F (2000) Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch Microbiol 174:422–428
Jones JB, Sih CJ, Perlman D (1976) Applications of biochemical systems in organic chemistry. Wiley, New York, pp 69–70
Zubik L, Meydani M (2003) Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr 77:1459–1465
Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, Jakate AS, Creutzinger V, Heubi JE (2003) Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 133:1027–1035
Sfakianos J, Coward L, Kirk M, Barnes S (1997) Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr 127:1260–1268
Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, Arai Y, Mazur W, Wahala K, Adlercreutz H (1998) Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr 128:1710–1715
Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308:1635–1638
Holdeman LV, Good IJ, Moore WE (1976) Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl Environ Microbiol 31:359–375
Decroos K, Vanhemmens S, Cattoir S, Boon N, Verstraete W (2005) Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Arch Microbiol 183:45–55
Acknowledgments
We are grateful to Fumio Miake of the Department of Microbiology, Faculty of Pharmaceutical Sciences, Fukuoka University, and Hidenori Kaminishi of the Department of Infection Biology, Fukuoka Dental College, for kindly suggestions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsuchihashi, R., Sakamoto, S., Kodera, M. et al. Microbial metabolism of soy isoflavones by human intestinal bacterial strains. J Nat Med 62, 456–460 (2008). https://doi.org/10.1007/s11418-008-0271-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11418-008-0271-y